发明名称 |
NPP1 FUSION PROTEINS |
摘要 |
The present invention provides a novel fusion polypeptide containing a catalytic domain of NPP1 fused to a targeting moiety, nucleic acids encoding the fusion polypeptide, a vector containing the nucleic acid integrated thereinto, a host cell transformed with the vector and pharmaceutical compositions comprising the fusion polypeptide. |
申请公布号 |
US2015024460(A1) |
申请公布日期 |
2015.01.22 |
申请号 |
US201414507124 |
申请日期 |
2014.10.06 |
申请人 |
SYNAGEVA BIOPHARMA CORP. |
发明人 |
Quinn Anthony;Harvey Alex J;Xia Zhinan |
分类号 |
C12N9/16 |
主分类号 |
C12N9/16 |
代理机构 |
|
代理人 |
|
主权项 |
1. An isolated NPP1 fusion protein, comprising an NPP1 component, and an Fc region of an immunoglobulin, wherein a) the NPP1 component comprises the cysteine-rich region and the C-terminus catalytic domain of NPP1, b) the Fc region is located C-terminally to the NPP1 component, and c) the isolated NPP1 fusion protein has NPP1 enzymatic activity. |
地址 |
LEXINGTON MA US |